Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The gene expression profile of primary BMMs differentiating into osteoclasts after knockout of solute carrier family 11 member 2 (SLC11A2)

ABSTRACT: The gene expression profile of primary BMMs differentiating into osteoclasts after knockout of solute carrier family 11 member 2 (SLC11A2)

PROVIDER: PRJNA1194049 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

The gene expression profile of primary BMMs differentiating into osteoclasts after knockout of solute carrier family 11 member 2 (SLC11A2)

Project description:To investigate the effect of solute carrier family 11 member 2 (SLC11A2) knockout on osteoclast differentiation, BMMs were extracted from the femurs of SLC11A2 knockout mice and the same litter of control mice, treated with RANKL, and then rna sequencing was performed.

2024-12-15 | GSE283491 | GEO

Expression profiles of BMMs and osteoclasts

Project description:Expression profiles of BMMs and osteoclasts

| PRJNA987598 | ENA

High-throughput sequencing analysis of BMMs and BMMs-derived osteoclasts

Project description:High-throughput sequencing analysis of BMMs and BMMs-derived osteoclasts

| PRJNA555428 | ENA

Solute carrier family 12 member 5 promotes tumor development of intrahepatic cholangiocarcinoma

Project description:Solute carrier family 12 member 5 promotes tumor development of intrahepatic cholangiocarcinoma

| PRJNA911841 | ENA

Effect of NVP-BHG712 treatment on gene expression of BMMs differentiating into osteoclasts.

Project description:To investigate the effect of NVP-BHG712 on osteoclast differentiation, BMMs were removed from femorae of C57BL/6 mice and treated with NVP-BHG712 for RNA-seq

2024-12-01 | GSE261350 | GEO

Effect of NVP-BHG712 treatment on gene expression of BMMs differentiating into osteoclasts.

Project description:Effect of NVP-BHG712 treatment on gene expression of BMMs differentiating into osteoclasts.

| PRJNA1086539 | ENA

Solute carrier family 12 member 5 promotes tumor development of intrahepatic cholangiocarcinoma

Project description:Intrahepatic cholangiocarcinoma (ICC) is the second most common primary malignant tumor of the liver, characterized by high malignancy, poor prognosis, and lack of effective treatment.Solute carrier family 12 member 5 (SLC12A5) is frequently overexpressed in many tumors and is involved in the development and progression of several human cancers. Here, we aimed to investigate the expression and biological function of SLC12A5 in ICC.

2023-02-01 | GSE220911 | GEO

Expression profiles of BMMs and osteoclasts

Project description:To profile the overall transcriptomic changes, we performed RNA-seq with bone marrow macrophages (BMM) before and after osteoclast differentiation (day 0 vs day 4). To induce mature osteoclasts formation, BMM were seeded and culture with customized αMEM containing 1/50 CMG14-12 supernatant and 75 ng/ml RANKL for 4 days.

2024-01-31 | GSE235773 | GEO

High-throughput sequencing analysis of BMMs and BMMs-derived osteoclasts

Project description:Long noncoding RNAs (lncRNAs) have emerged as integral regulators of physiology and disease, but specific roles of lncRNAs in bone resorption remain largely unknown. Here, RNA-seq analysis indicated that lncRNA Nron was a candidate funtional regulators of bone resorption. Our further experimental analysis showed that Nron regulates bone resorption in mice. We further identified a functional motif of Nron. Consequently, delivery of Nron functional motif specifically in osteoclasts reversed bone loss without obvious side-effects in vivo. Together, our study indicate that Nron is a key bone resorption suppressor and reveal Nron functional motif might be a potential therapeutic strategy to combat excessive bone absorption in osteoporosis.

2019-07-19 | GSE134457 | GEO

Dissecting the novel molecular interactions of solute carrier family 4 member 4 (SLC4A4) for prostate cancer (PCa) progression

Project description:Dissecting the novel molecular interactions of solute carrier family 4 member 4 (SLC4A4) for prostate cancer (PCa) progression

| PRJNA876728 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data